首页 | 本学科首页   官方微博 | 高级检索  
     

分泌型糖基化代谢终末产物受体与2型糖尿病合并急性冠状动脉综合征的相关研究
引用本文:施珍,王瑞良,陈书艳. 分泌型糖基化代谢终末产物受体与2型糖尿病合并急性冠状动脉综合征的相关研究[J]. 临床荟萃, 2011, 26(18): 1578-1580
作者姓名:施珍  王瑞良  陈书艳
作者单位:上海交通大学医学院附属新华医院老年科,上海,200092
摘    要:目的探讨内源性分泌型糖基化代谢终末产物受体(esRAGE)与2型糖尿病(T2DM)合并急性冠状动脉综合征(ACS)的关系。方法将研究对象分成3组,单纯糖尿病组(DM组)24例,糖尿病合并冠心病组(DM合并CAD组)24例,糖尿病合并急性冠状动脉综合征组(DM合并ACS组)25例。用酶联免疫法检测血清esRAGE水平,并检测其他临床指标。结果 DM合并ACS组的糖化血红蛋白(HbA1c)高于DM组和DM合并CAD组,分别为(8.68±2.35)%vs(6.78±0.73)%,(7.22±1.12)%(均P〈0.01),血清esRAGE DM合并CAD组和DM合并ACS组明显低于DM组,分别为(0.52±0.04)μg/L,(0.35±0.07)μg/L vs(0.71±0.08)μg/L(均P〈0.01),Pearson相关分析显示esRAGE与HbA1c呈负相关(r=-0.344,P〈0.01)。结论 esRAGE与T2DM密切相关,对糖尿病大血管并发症可能有潜在保护作用。

关 键 词:糖尿病,2型  冠状动脉疾病  糖基化代谢终末产物受体  酶联免疫吸附测定

Association of endogenous secretory receptor for advanced glycation end productswith acute coronary syndrome in type 2 diabetes mellitus
SHI Zhen,WANG Rui-liang,CHEN Shu-yan. Association of endogenous secretory receptor for advanced glycation end productswith acute coronary syndrome in type 2 diabetes mellitus[J]. Clinical Focus, 2011, 26(18): 1578-1580
Authors:SHI Zhen  WANG Rui-liang  CHEN Shu-yan
Affiliation:SHI Zhen,WANG Rui-liang,CHEN Shu-yan Department of Geriatrics,Xinhua Hospital,Shanghai Jiaotong University of Medicine,Shanghai 200092,China
Abstract:Objective To evaluate the association of endogenous secretory receptor for advanced glycation end products(esRAGE) with acute coronary syndrome(ACS) in type 2 diabetes mellitus. Methods 73 patients with type 2 diabetes mellitus(T2DM) were divided into three groups,including 24 patients with T2DM only,24 patients with coronary artery disease(CAD) and 25 patients with ACS.Enzyme-linked immunosorbent assay(ELISA) was used to detect the serum esRAGE of all the patients,other clinical indexes were also tested. R...
Keywords:diabetes mellitus  type 2  coronary disease  endogenous secretory receptor for advanced glycation end products  enzyme-linked immunosorbent assay  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号